Clinical Trials Logo

Clinical Trial Summary

Mutations in the MARS gene encoding methionyl-tRNA synthetase are responsible for a genetic form of alveolar proteinosis (PAP), but the pathophysiological mechanisms of the respiratory phenotype are not known. The main hypothesis is that the PAP phenotype in these patients is secondary to a defective clearance of the surfactant by the alveolar macrophages. The main objective of the study is to study the clearance capacity of lipoproteinaceous material by macrophages of patients with MARS related PAP. This will be investigate in cultured macrophages derived from peripheral blood monocytes of patients (patients with MARS related PAP) and controls (patients without MARS related PAP).


Clinical Trial Description

Pulmonary alveolar proteinosis (PAP) is a rare respiratory disease characterized by the accumulation of lipoproteinaceous material within the pulmonary alveoli, resulting in the majority of cases from a defective clearance of the surfactant by intra-alveolar macrophages. Mutations in the MARS gene encoding methionyl-tRNA synthetase are responsible for a genetic form of alveolar proteinosis, but the pathophysiological mechanisms leading to mutations in the respiratory phenotype are not known. The main hypothesis is that the alveolar proteinosis phenotype in these patients is secondary to a defective clearance of the surfactant by the alveolar macrophages. The main objective of the study is to study the clearance capacity of lipoproteinaceous material by macrophages of patients with MARS related PAP. This will be investigate in cultured macrophages derived from peripheral blood monocytes of patients (patients with MARS related PAP) and controls (patients without MARS related PAP). The subjects and the controls will be included during a hospitalization during which a blood sample and a bronchoscopy with broncoalveolar lavage must be performed as part of their care. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04811274
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Alice HADCHOUEL, MD, PhD
Phone 1 44 49 48 47
Email alice.hadchouel-duverge@aphp.fr
Status Recruiting
Phase
Start date June 7, 2021
Completion date June 7, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06055595 - Genetic Factors and CP Pregnancy Outcomes
Active, not recruiting NCT04574297 - An Observational Study on the Natural Course of Chronic Pancreatitis
Recruiting NCT05691036 - Bile Acids Metabolism and Genetic Mutation Profile in the ICP in the Indian Population
Completed NCT04830787 - Correlation Between Myocardial Deformation and Coronary Artery Tortuosity in Patients With Hypertrophic Cardiomyopathy
Active, not recruiting NCT03043508 - Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)